Skip to main content

Want a detailed portfolio tracker?

Bellevue Life Sciences Acquisition (OSRH) P/E (2025 - 2026)

Bellevue Life Sciences Acquisition (OSRH) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Bellevue Life Sciences Acquisition (OSRH) P/E is -0.56. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Bellevue Life Sciences Acquisition (OSRH)

YearP/EChange
2026-0.56+26.22%
2025-0.45N/A

Comparison Bellevue Life Sciences Acquisition (OSRH) P/E with competitors

Bellevue Life Sciences Acquisition (OSRH) P/E is -0.56.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.30%
NBYStablecoin Development Corp0.00-100.76%
ENLVEnlivex Ltd0.07-113.26%
FGENFibroGen Inc0.24-142.55%
CHRSCoherus Biosciences Inc0.85-250.42%
FBIOFortress Biotech Inc0.95-268.24%
AGENAgenus Inc3.01-633.53%
INVAInnoviva Inc3.15-659.13%
VXRTVaxart Inc3.55-729.27%
CRMDCorMedix Inc3.63-743.23%
CVACCureVac N.V.4.45-888.10%
GLPGGalapagos NV4.86-961.35%
SRPTSarepta Therapeutics Inc4.88-965.47%
ABEOAbeona Therapeutics Inc5.39-1055.06%
ABUSArbutus Biopharma Corp5.60-1091.96%
ZVRAZevra Therapeutics Inc5.89-1143.65%
SPROSpero Therapeutics Inc6.23-1204.14%
CGENCompugen Ltd6.31-1219.30%
RIGLRigel Pharmaceuticals6.87-1318.24%
SLXNSilexion Therapeutics Corp7.30-1393.40%
OMEROmeros Corporation9.26-1741.33%
AUPHAurinia Pharmaceuticals Inc9.58-1799.16%
PLXProtalix BioTherapeutics Inc10.89-2030.69%
ACADAcadia Pharmaceuticals Inc11.73-2179.16%
TBPHTheravance Biopharma Inc12.26-2273.76%
ADMAAdma Biologics Inc12.42-2301.42%
HRMYHarmony Biosciences Holdings Inc13.82-2549.96%
SABSSAB Biotherapeutics Inc14.14-2605.98%
NAGENiagen Bioscience Inc14.82-2726.87%
INCYIncyte Corp15.82-2904.93%
REGNRegeneron Pharmaceuticals Inc15.86-2910.98%
PBYIPuma Biotechnology Inc17.32-3169.63%
CPRXCatalyst Pharmaceuticals Inc17.44-3191.54%
EXELExelixis Inc17.54-3209.04%
TGTXTG Therapeutics Inc18.97-3462.20%
MDXGMimedx Group Inc20.55-3743.43%
XOMAXOMA Royalty Corp22.87-4155.20%
ARGXArgen X SE24.30-4407.53%
CTMXCytomX Therapeutics Inc24.82-4500.26%
XOMAOXOMA Royalty Corp25.34-4593.10%
HALOHalozyme Therapeutics Inc25.62-4642.55%
XOMAPXOMA Royalty Corp25.67-4650.77%
VRTXVertex Pharmaceuticals Inc27.99-5062.88%
RPRXRoyalty Pharma plc - Class A28.69-5185.70%
SLNOSoleno Therapeutics Inc29.02-5243.81%
ASNDAscendis Pharma A/S30.09-5433.54%
LGNDLigand Pharmaceuticals Inc - Class B37.91-6821.01%
APLSApellis Pharmaceuticals Inc39.02-7017.65%
BMRNBiomarin Pharmaceutical Inc42.21-7583.28%
KRYSKrystal Biotech Inc45.34-8138.45%
ONCBeiGene Ltd69.54-12428.07%
PHARPharming Group N.V.75.03-13400.47%
TECHBio-Techne Corp101.96-18175.10%
VCELVericel Corp109.92-19586.76%
ALNYAlnylam Pharmaceuticals Inc117.96-21012.76%
GMABGenmab140.29-24970.63%
TLXTelix Pharmaceuticals Ltd162.15-28846.32%
CORTCorcept Therapeutics Inc212.86-37835.21%